Brookfield's equity infusion crucial for Indostar Capital in Q1 FY21: CARE

Besides challenges faced by wholesale NBFC in particular, the credit costs (amount to be provided for stressed assets), are likely increase post outbreak of COVID 19

taxes, funds, revenue, audit, income, salary, balance, revenue, receipts, collections
Abhijit Lele Mumbai
2 min read Last Updated : Apr 20 2020 | 8:01 PM IST
An equity infusion of Rs 1,225 crore by Brookfield Business Partners into Indostar Capital Finance Ltd (ICF) in first quarter of FY21 is crucial to ensure adequate liquidity when NBFC sector is facing challenges in resource mobilization after COVID outbreak.

Rating agency CARE has placed the ratings of Indostar Capital’s ted on credit watch with developing implications. The long-term debt carries “AA-“ rating.

Besides challenges faced by wholesale NBFC in particular, the credit costs (amount to be provided for stressed assets), are likely increase post outbreak of COVID 19. The said equity infusion would be critical for ICF as it would lead to further improvement in the liquidity position of ICF, CARE said in statement.


CARE takes note of resource mobilisation of over Rs 3,763.5 crore from various sources done by Indostar Capital Finance Limited from December 2018 to December 2019. However, in line with trend observed for the NBFC/HFC sector, ICFL has also witnessed increased cost of borrowings.

CARE will take a view on the ratings of ICF post completion of the said equity transaction along with the prevalent asset quality parameters and liquidity maintained during this tough operating environment.

The ratings of ICF primarily factor in strong institutional sponsors of ICF as well as their capital, operational and management support. The company has experienced management, good risk management processes. It has shown increasing proportion of retail advances and efforts to diversify into retail segments and has strong capitalization levels and comfortable gearing, comfortable asset quality parameters & liquidity position, CARE said.


Indostar in January 31, 2020, had said the overall investment was a combination of primary investment in equity shares and compulsorily convertible preference shares of Rs 1,225 crore. This was along with a secondary purchase of shares from IndoStar Capital Mauritius. Brookfield will also become a co-promoter in IndoStar and nominate two board members. Indostar Capital share closed almost flat at Rs 270 o per share on BSE.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusIndoStar CapitalIndoStar Capital FinanceNBFCsliquidity crisis

Next Story